awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27851579-D3AE3121-22DB-474D-9672-B306313985C1
Q27851579-D3AE3121-22DB-474D-9672-B306313985C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27851579-D3AE3121-22DB-474D-9672-B306313985C1
Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3.
P2860
Q27851579-D3AE3121-22DB-474D-9672-B306313985C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27851579-D3AE3121-22DB-474D-9672-B306313985C1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1f8f6fa1d4c350297cea532083120cd2efbb1291
P2860
Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain.